Patents by Inventor Scott Eugene McGraw

Scott Eugene McGraw has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline(?)-3R,4R-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}chromane, hydrogen maleate
    Patent number: 6372776
    Abstract: The present invention provides novel crystalline (−)-3R,4R-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}chromane, hydrogen maleate useful for reducing or preventing bone loss as well as pharmaceutical compositions containing the same. A process for preparing (−)-3R,4R-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}chromane, hydrogen maleate is described.
    Type: Grant
    Filed: June 8, 1998
    Date of Patent: April 16, 2002
    Assignee: Novo Nordisk A/S
    Inventors: Svend Treppendahl, Klaus Snej Jensen, Scott Eugene McGraw
  • CRYSTALLINE(-)-3R,4R-TRANS-7METHOXY-2,2-DIMETHYL-3-PHENYL-4-{4-[2- (PYRROLIDIN-1-YL)ETHOXY]PHENY 1}CHROMANE, HYDROGEN MALETE
    Publication number: 20020004520
    Abstract: The present invention provides novel crystalline (−)−3R,4R-trans-7-methoxy-2, 2-dimethyl-3-phenyl-4-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}chromane, hydrogen maleate useful for reducing or preventing bone loss as well as pharmaceutical compositions containing the same. A process for preparing (−)−3R,4R-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-{4-[2-(pyrrolidin-1-yl) ethoxy]phenyl}chromane, hydrogen maleate is described.
    Type: Application
    Filed: June 8, 1998
    Publication date: January 10, 2002
    Inventors: SVEND TREPPENDHAL, KLAUS SNEJ JENSEN, SCOTT EUGENE MCGRAW
  • Acid addition salts of 2, 3, 4, 5-tetrahydro-1H-3-benzazepine compounds
    Patent number: 5658899
    Abstract: The invention provides a series of crystalline salts of (S)-8-chloro-5-(5-bromo-2,3-dihydrobenzofuran-7-yl)-3-methyl-2,3,4,5-tetra hydro-1H-3-benzazepine-7-ol, their preparation and use as therapeutic agents.
    Type: Grant
    Filed: March 14, 1995
    Date of Patent: August 19, 1997
    Assignee: Novo Nordisk A/S
    Inventors: Louis Brammer Hansen, Rolf Emil Amsler, Scott Eugene McGraw